Cardiovascular Disease Mortality in Mississippi, 2000-2018.
Journal
Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018
Informations de publication
Date de publication:
24 02 2022
24 02 2022
Historique:
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Cardiovascular disease (CVD) is the leading of cause of death in Mississippi. We explored trends in CVD death rates among adults in Mississippi aged 35 years or older to assess changes from 2000 through 2018. We extracted data from Mississippi Vital Statistics from 2000 through 2018. We used underlying cause-of-death codes from the International Classification of Diseases, Tenth Revision (ICD-10) to identify CVD deaths; we included all cases with codes I00-I09, I11, I13, I20-I51, I60-I69, and I70. We calculated age-adjusted CVD death rates for the overall population by age, race, sex, and race-by-sex groups. Overall, the age-adjusted CVD death rate declined from 832.3 deaths per 100,000 population in 2000 to 550.5 deaths per 100,000 in 2018, a relative decline of 33.9% and an average annual decline of -2.3% (95% CI, -2.7% to -1.8%). Age-adjusted CVD death rates declined from 2000 through 2018 for all groups, but the magnitude of decline varied by subgroup (men, -2.0%; women, -2.6%; non-Hispanic Black, -2.4%; non-Hispanic White, -2.2%; non-Hispanic Black women, -3.0%; non-Hispanic White women, -2.5%; non-Hispanic Black men -2.1%; non-Hispanic White men -2.0%). Age-specific analysis indicated a significant average annual increase of 1.7% (95% CI, 0.6%-2.9%) from 2011 through 2018 for the group aged 55 to 64 years. From 2000 through 2018, age-adjusted CVD death rates in Mississippi declined for all age/race/sex groups. However, the magnitude of decline varied by subgroup. Targeted interventions for CVD risk reduction are needed for adults aged 55 to 64 years in Mississippi, the only age group in which we observed a significant annual increase in CVD death rates.
Identifiants
pubmed: 35201975
doi: 10.5888/pcd19.210385
pii: E09
pmc: PMC8880103
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
E09Références
Prev Chronic Dis. 2017 Jun 22;14:E49
pubmed: 28641072
Int J Hypertens. 2020 Jul 16;2020:2401747
pubmed: 32724672
BMC Public Health. 2021 Jan 6;21(1):50
pubmed: 33407308
PLoS One. 2016 Feb 16;11(2):e0149015
pubmed: 26882207
Curr Epidemiol Rep. 2014 Jun 1;1(2):82-88
pubmed: 24977112
BMC Nephrol. 2019 Jan 10;20(1):11
pubmed: 30630437
JAMA Netw Open. 2021 Nov 1;4(11):e2136022
pubmed: 34846526
PLoS Med. 2006 Sep;3(9):e260
pubmed: 16968116
Am J Med Sci. 2000 Mar;319(3):131-7
pubmed: 10746822
JAMA Cardiol. 2016 Aug 1;1(5):594-9
pubmed: 27438477
JAMA. 2017 May 16;317(19):1976-1992
pubmed: 28510678
JAMA Cardiol. 2018 May 1;3(5):375-389
pubmed: 29641820
N Engl J Med. 2007 Jun 7;356(23):2388-98
pubmed: 17554120
Prev Chronic Dis. 2014 Jul 24;11:E126
pubmed: 25058672
J Epidemiol. 2016;26(4):191-8
pubmed: 26639750
Healthy People 2010 Stat Notes. 2001 Jan;(20):1-10
pubmed: 11676466
Biometrics. 2007 Mar;63(1):22-32
pubmed: 17447926
PLoS One. 2016 Aug 12;11(8):e0161194
pubmed: 27518895
Prev Chronic Dis. 2019 Feb 14;16:E21
pubmed: 30767859
Circ Res. 2017 Jan 20;120(2):366-380
pubmed: 28104770
Prev Chronic Dis. 2015 Feb 19;12:E21
pubmed: 25695259
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1384-91
pubmed: 27340284
Epidemiol Res Int. 2014 Jan 1;2014(Article 499 861461):861461
pubmed: 25844257
Stroke. 2014 Jan;45(1):315-53
pubmed: 24309587
Hypertension. 2008 Mar;51(3):650-6
pubmed: 18268140